Pages that link to "Q33690338"
Jump to navigation
Jump to search
The following pages link to Her2 activates NF-kappaB and induces invasion through the canonical pathway involving IKKalpha (Q33690338):
Displaying 50 items.
- FER tyrosine kinase (FER) overexpression mediates resistance to quinacrine through EGF-dependent activation of NF-κB (Q24300387) (← links)
- A NIK-IKKα module expands ErbB2-induced tumor-initiating cells by stimulating nuclear export of p27/Kip1 (Q24338768) (← links)
- The NF-κB Pathway and Cancer Stem Cells (Q26750605) (← links)
- Increased IKKα expression in the basal layer of the epidermis of transgenic mice enhances the malignant potential of skin tumors (Q27332624) (← links)
- HER2 and uPAR cooperativity contribute to metastatic phenotype of HER2-positive breast cancer (Q28085413) (← links)
- Enhanced anticancer activity of DM1-loaded star-shaped folate-core PLA-TPGS nanoparticles (Q28654503) (← links)
- BMP9 inhibits proliferation and metastasis of HER2-positive SK-BR-3 breast cancer cells through ERK1/2 and PI3K/AKT pathways (Q33578209) (← links)
- Pathway-based analysis of breast cancer (Q33758011) (← links)
- IKK is a therapeutic target in KRAS-Induced lung cancer with disrupted p53 activity (Q33776852) (← links)
- Inhibition of specific NF-κB activity contributes to the tumor suppressor function of 14-3-3σ in breast cancer (Q34295493) (← links)
- Negative regulation of NF-κB by the ING4 tumor suppressor in breast cancer (Q34442193) (← links)
- Identification of novel determinants of resistance to lapatinib in ERBB2-amplified cancers (Q34615545) (← links)
- Transducin β-like protein 1 recruits nuclear factor κB to the target gene promoter for transcriptional activation. (Q34742213) (← links)
- C/EBPα, C/EBPα Oncoproteins, or C/EBPβ Preferentially Bind NF-κB p50 Compared with p65, Focusing Therapeutic Targeting on the C/EBP:p50 Interaction (Q35387968) (← links)
- PARP1 and phospho-p65 protein expression is increased in human HER2-positive breast cancers (Q35410911) (← links)
- Blocking IKKα Expression Inhibits Prostate Cancer Invasiveness (Q35528755) (← links)
- Canonical and non-canonical NF-κB signaling promotes breast cancer tumor-initiating cells (Q35586803) (← links)
- Progesterone Receptor Inhibits Proliferation of Human Breast Cancer Cells via Induction of MAPK Phosphatase 1 (MKP-1/DUSP1) (Q35604651) (← links)
- NF-κB, stem cells and breast cancer: the links get stronger (Q35608668) (← links)
- In vitro and in vivo antitumoral effects of combinations of polyphenols, or polyphenols and anticancer drugs: perspectives on cancer treatment (Q35722741) (← links)
- ErbB2 activation upregulates glutaminase 1 expression which promotes breast cancer cell proliferation (Q35899955) (← links)
- Sarcosine induces increase in HER2/neu expression in androgen-dependent prostate cancer cells (Q36108457) (← links)
- Retracted: Plumbagin Suppresses the Invasion of HER2-Overexpressing Breast Cancer Cells through Inhibition of IKKα-Mediated NF-κB Activation (Q36160375) (← links)
- HER2 overexpression renders human breast cancers sensitive to PARP inhibition independently of any defect in homologous recombination DNA repair (Q36280791) (← links)
- An in vitro study showing the three-dimensional microenvironment influence over the behavior of head and neck squamous cell carcinoma (Q36332304) (← links)
- Opposed expression of IKKα: loss in keratinizing carcinomas and gain in non-keratinizing carcinomas (Q36413217) (← links)
- Trastuzumab-Resistant Luminal B Breast Cancer Cells Show Basal-Like Cell Growth Features Through NF-κB-Activation (Q36630127) (← links)
- Synchronized Targeting of Notch and ERBB Signaling Suppresses Melanoma Tumor Growth through Inhibition of Notch1 and ERBB3. (Q36682137) (← links)
- HER2 drives luminal breast cancer stem cells in the absence of HER2 amplification: implications for efficacy of adjuvant trastuzumab. (Q36693285) (← links)
- The HER2- and heregulin β1 (HRG)-inducible TNFR superfamily member Fn14 promotes HRG-driven breast cancer cell migration, invasion, and MMP9 expression (Q36780754) (← links)
- Resveratrol chemosensitizes HER-2-overexpressing breast cancer cells to docetaxel chemoresistance by inhibiting docetaxel-mediated activation of HER-2-Akt axis (Q37164515) (← links)
- Role of NF-κB as a Prognostic Marker in Breast Cancer : A Pilot Study in Indian Patients (Q37165541) (← links)
- NF-kappaΒ-inducing kinase regulates stem cell phenotype in breast cancer. (Q37431321) (← links)
- Lapatinib-induced NF-kappaB activation sensitizes triple-negative breast cancer cells to proteasome inhibitors (Q37690966) (← links)
- Role of IKKα in skin squamous cell carcinomas (Q37822741) (← links)
- Predictive biomarkers for cancer therapy with PARP inhibitors. (Q38137764) (← links)
- Targeting the NFκB signaling pathways for breast cancer prevention and therapy. (Q38267049) (← links)
- The role of RelA (p65) threonine 505 phosphorylation in the regulation of cell growth, survival, and migration (Q38274559) (← links)
- Peroxiredoxin-2 Upregulated by NF-κB Attenuates Oxidative Stress During the Differentiation of Muscle-Derived C2C12 Cells (Q39477331) (← links)
- Different expression patterns of pAkt, NF‐κB and cyclin D1 proteins during the invasion process of head and neck squamous cell carcinoma: an in vitro approach (Q39641050) (← links)
- Identification of new miRNA biomarkers associated with HER2-positive breast cancers (Q40178092) (← links)
- Dimerization of EGFR and HER2 induces breast cancer cell motility through STAT1-dependent ACTA2 induction. (Q41612212) (← links)
- Lin28 and HER2: two stem cell regulators conspire to drive aggressive breast cancer (Q43241505) (← links)
- Release of HER2 repression of trefoil factor 3 (TFF3) expression mediates trastuzumab resistance in HER2+/ER+ mammary carcinoma (Q47114555) (← links)
- NF-kappaB: Two Sides of the Same Coin. (Q47556651) (← links)
- HER2 overexpression triggers an IL-1α pro-inflammatory circuit to drive tumorigenesis and promote chemotherapy resistance (Q49571851) (← links)
- Nuclear NF-κB/p65 expression and response to neoadjuvant chemotherapy in breast cancer (Q54627424) (← links)
- ETS1 is associated with cisplatin resistance through IKKα/NF-κB pathway in cell line MDA-MB-231. (Q55315341) (← links)
- Cancer stem cells and HER2 positive breast cancer: The story so far (Q57120564) (← links)
- The Cytotoxic and Antimigratory Activity of Brazilin-Doxorubicin on MCF-7/HER2 Cells (Q57136097) (← links)